1
|
Waissengrin B, Abo Atta B, Merimsky O, Shamai S, Waller E, Wolf I, Laufer Peerl M. EP08.01-010 Troponin Elevation and the Risk of Myocarditis among NSCLC Patients Treated with Immune Checkpoint Inhibitors. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.582] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
2
|
Shachar E, Hasson SP, Ferro L, Pundak C, Nikolaevski-Berlin A, Waller E, Safra T, Rubinek T, Wolf I. Real-life daily activity: the impact of misbeliefs on quality of life among cancer patients. ESMO Open 2022; 7:100498. [PMID: 35642988 PMCID: PMC9271513 DOI: 10.1016/j.esmoop.2022.100498] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2022] [Revised: 04/18/2022] [Accepted: 04/24/2022] [Indexed: 11/30/2022] Open
Abstract
Background While side-effects and health-related quality of life (QoL) are routinely assessed in clinical trials, commonly used tools do not measure patients’ ability to maintain normal daily activities. QoL can be severely affected directly by the disease, the treatment side-effects and by personal and societal misconceptions promoting avoidance from activities perceived as dangerous for cancer patients. We examined practices of actively treated patients with cancer. Methods A questionnaire was designed, assessing daily activities (11 items) and dietary limitations (7 items) distributed between October and December 2019 (before the coronavirus pandemic) among patients treated at the Oncology Division of Tel Aviv Sourasky Medical Center. Results The study population comprised 208 patients who participated in the survey. The majority reported at least one social-environmental avoidance or dietary limitation (136, 65% and 120, 57.7%, respectively), including abstaining from social contact, avoiding pets, public domains, traveling and maintaining dietary constraints. Adoption of these measures was not associated with clinical, demographic factors and treatment type. The major sources guiding restrictions came from advice of non-medical personnel (55.7%), the Internet (7.2%) and personal choice by the patients themselves (24%). Conclusions Most cancer patients reported compromised daily activities, which are likely attributed to misbeliefs about disease and treatment, and have a deleterious impact on QoL, in its wider sense, namely, the ability to conduct a full and meaningful life. These findings call for the development and implementation of tools examining patients’ real-life activity, beyond side-effects or health-related QoL (HRQoL). We propose this assessment as an integral part in the evaluation of new drugs and technologies and as an additional endpoint in pivotal clinical trials. Side-effects and HRQoL routinely assessed in clinical trials do not fully measure patients’ maintenance of daily activities. We developed a questionnaire examining daily practices and implications of misbeliefs among actively treated cancer patients. Most patients reported compromised daily activities, affecting QoL in its wider sense: conducting a full and meaningful life. These findings call for the development and implementation of tools examining patients’ real-life activity, beyond HRQoL. We propose accounting for a more comprehensive assessment of QoL, and patient health care education dispelling misbeliefs.
Collapse
Affiliation(s)
- E Shachar
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Division of Oncology, Tel Aviv Sourasky Medical Center, Israel
| | - S P Hasson
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Division of Oncology, Tel Aviv Sourasky Medical Center, Israel
| | - L Ferro
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Division of Oncology, Tel Aviv Sourasky Medical Center, Israel
| | - C Pundak
- Division of Psychology, Tel Aviv University, Israel
| | | | - E Waller
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Division of Oncology, Tel Aviv Sourasky Medical Center, Israel
| | - T Safra
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Division of Oncology, Tel Aviv Sourasky Medical Center, Israel
| | - T Rubinek
- Division of Oncology, Tel Aviv Sourasky Medical Center, Israel
| | - I Wolf
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Division of Oncology, Tel Aviv Sourasky Medical Center, Israel.
| |
Collapse
|
3
|
Bachanova V, Westin J, Tam C, Borchmann P, Jaeger U, McGuirk J, Holte H, Waller E, Jaglowski S, Bishop M, Andreadis C, Foley S, Fleury I, Teshima T, Mielke S, Salles G, Ho P, Izutsu K, Maziarz R, Van Besien K, Kersten M, Wagner-Johnston N, Kato K, Corradini P, Han X, Agoulnik S, Chu J, Eldjerou L, Pacaud L, Schuster S. CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL-TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS. Hematol Oncol 2019. [DOI: 10.1002/hon.118_2630] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- V. Bachanova
- Division of Hematology; Oncology and Transplantation, University of Minnesota; Minneapolis United States
| | - J. Westin
- Department of Lymphoma & Meyloma; M.D. Anderson Cancer Center; Houston United States
| | - C. Tam
- Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - P. Borchmann
- Department of Hematology/Oncology; University Hospital of Cologne; Cologne Germany
| | - U. Jaeger
- Department of Hematology/Hemostaseology; Medical University Vienna; Vienna Austria
| | - J. McGuirk
- Division of Hematologic Malignancies and Cellular Therapeutics; Kansas Hospital and Medical Center; Kansas City United States
| | - H. Holte
- Lymphoma Section; University of Oslo; Oslo Norway
| | - E. Waller
- Department of Stem Cell Transplantation and Immunology; Emory University School of Medicine; Atlanta United States
| | - S. Jaglowski
- Department of Internal Medicine; The Ohio State University; Columbus United States
| | - M. Bishop
- Section of Hematology/Oncology; University of Chicago; Chicago United States
| | - C. Andreadis
- Department of Hematology and Blood and Marrow Transplat; University of California San Francisco; San Francisco United States
| | - S.R. Foley
- Division of Clinical Pathology; McMaster University; Hamilton Canada
| | - I. Fleury
- Department of Hematology; Hôpital Maisonneuve-Rosemont; Montreal Canada
| | - T. Teshima
- Department of Hematology; Hokkaido University Hospital; Sapporo Japan
| | - S. Mielke
- Department of Internal Medicine; University Hospital Wuerzburg; Wuerzburg Germany
| | - G. Salles
- Hematology Department; Lyon-Sud Hospital Center; Pierre-Benite France
| | - P.J. Ho
- Department of Haematology; Royal Prince Alfred Hospital; Camperdown Australia
| | - K. Izutsu
- Department of Hematology; National Cancer Center Hospital; Tokyo Japan
| | - R. Maziarz
- Department of Hematology and Oncology; Oregon Health and Science University; Portland United States
| | - K. Van Besien
- Department of Medical Oncology; Weill Cornell Medicine; New York United States
| | - M.J. Kersten
- Department of Hematology; Academic Medical Center; Amsterdam Netherlands
| | - N. Wagner-Johnston
- Department of Oncology and Hematologic Malignancies; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center; Baltimore United States
| | - K. Kato
- Hematology; Oncology & Cardiovascular Medicine, Kyushu University; Fukuoka Prefecture Japan
| | - P. Corradini
- Department of Oncology and Hemato-oncology; University of Milan; Milan Italy
| | - X. Han
- Biomarkers and Diagnostics Biometrics; Novartis Pharmaceuticals Corporation; East Hanover United States
| | - S. Agoulnik
- Precision Medicine; Novartis Pharmaceuticals Corporation; Cambridge United States
| | - J. Chu
- Novartis Oncology; Novartis Pharmaceuticals Corporation; East Hanover United States
| | - L. Eldjerou
- Global Cell & Gene Medical Affairs; Novartis Pharmaceuticals Corporation; East Hanover United States
| | - L. Pacaud
- Novartis Oncology; Novartis Pharmaceuticals Corporation; East Hanover United States
| | - S. Schuster
- Division of Hematology Oncology; University of Pennsylvania; Philadelphia United States
| |
Collapse
|
4
|
Jaeger U, Tam C, Borchmann P, McGuirk J, Holte H, Waller E, Jaglowski S, Andreadis C, Foley S, Fleury I, Westin J, Teshima T, Mielke S, Salles G, Ho P, Izutsu K, Schuster S, Bachanova V, Maziarz R, Van Besien K, Kersten M, Wagner-Johnston N, Kato K, Corradini P, Tiwari R, Forcina A, Pacaud L, Bishop M. INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL. Hematol Oncol 2019. [DOI: 10.1002/hon.189_2631] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- U. Jaeger
- Hematology and Hemostaseology; and Comprehensive Cancer Center, Medical University of Vienna; Vienna Austria
| | - C. Tam
- Department of Hematology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - P. Borchmann
- Department of Hematology/Oncology; University Hospital of Cologne; Cologne Germany
| | - J. McGuirk
- Division of Hematologic Malignancies and Cellular Therapeutics; Kansas Hospital and Medical Center; Kansas City United States
| | - H. Holte
- Lymphoma Section; University of Oslo, Oslo
| | - E. Waller
- Hematology and Medical Oncology; Medicine and Pathology, Emory University School of Medicine; Atlanta United States
| | - S. Jaglowski
- Department of Hematology; Ohio State University, Columbus
| | - C. Andreadis
- Department of Hematology and Blood and Marrow Transplant; University of California San Francisco; San Francisco United States
| | - S.R. Foley
- Division of Clinical Pathology; McMaster University; Hamilton Canada
| | - I. Fleury
- Department of Hematology; Hôpital Maisonneuve-Rosemont; Montreal Canada
| | - J. Westin
- Department of Lymphoma & Meyloma; MD Anderson Cancer Center; Houston United States
| | - T. Teshima
- Department of Hematology; Hokkaido University Hospital; Sapporo Japan
| | - S. Mielke
- Department of Internal Medicine; University Hospital Wuerzburg; Wuerzburg Germany
| | - G. Salles
- Department of Hematology/Oncology; Hospital Center Lyon-Sud; Pierre-Benite France
| | - P.J. Ho
- Department of Haematology; Royal Prince Alfred Hospital; Camperdown Australia
| | - K. Izutsu
- Department of Hematology; National Cancer Center Hospital; Tokyo Japan
| | - S. Schuster
- Division of Hematology Oncology; University of Pennsylvania; Philadelphia United States
| | - V. Bachanova
- Division of Hematology; Oncology and Transplantation, University of Minnesota; Minneapolis United States
| | - R. Maziarz
- Department of Hematology; Oregon Health and Science University; Portland United States
| | - K. Van Besien
- Department of Medical Oncology; Weill Cornell Medicine; New York United States
| | - M.J. Kersten
- Department of Hematology; Academic Medical Center; Amsterdam Netherlands
| | - N. Wagner-Johnston
- Department of Hematology/Oncology; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center; Baltimore United States
| | - K. Kato
- Department of Haematology; Kyushu University Hospital; Fukuoka Prefecture Japan
| | - P. Corradini
- Department of Oncology and Hemato-oncology; University of Milan; Milan Italy
| | - R. Tiwari
- Global Medical Affaris; Novartis Pharmaceuticals Corporation; Hyderabad India
| | - A. Forcina
- Novartis Oncology; Novartis Pharma AG; Basel Switzerland
| | - L. Pacaud
- Novartis Oncology; Novartis Pharmaceuticals Corporation; East Hanover United States
| | - M. Bishop
- Section of Hematology/Oncology; University of Chicago; Chicago United States
| |
Collapse
|
5
|
Jaeger U, McGuirk J, Worel N, Riedell P, Fleury I, Borchmann P, Forcina A, Chu J, Leung M, Pacaud L, Waller E. PORTIA: A PHASE 1B STUDY EVALUATING SAFETY AND EFFICACY OF TISAGENLECLEUCEL AND PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA. Hematol Oncol 2019. [DOI: 10.1002/hon.7_2632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- U. Jaeger
- Hematology and Hemostaseology, and Comprehensive Cancer Center; Medical University of Vienna; Vienna Austria
| | - J. McGuirk
- Hematologic Malignancies and Cellular Therapeutics; Kansas Hospital and Medical Center; Kansas City United States
| | - N. Worel
- Hematology and Hemostaseology, and Comprehensive Cancer Center; Medical University of Vienna; Vienna Austria
| | - P. Riedell
- Biomedical Sciences; University of Chicago; Chicago United States
| | - I. Fleury
- Hematology; Hospital Maisonneuve-Rosemont; Montreal Canada
| | - P. Borchmann
- Hematology/Oncology; University Hospital of Cologne; Cologne Germany
| | - A. Forcina
- Novartis Oncology; Novartis Pharma AG; Basel Switzerland
| | - J. Chu
- Novartis Oncology; Novartis Pharmaceuticals Corporation; East Hanover United States
| | - M. Leung
- Oncology Clinical Development; Novartis Pharmaceuticals Corporation; East Hanover United States
| | - L. Pacaud
- Novartis Oncology; Novartis Pharmaceuticals Corporation; East Hanover United States
| | - E. Waller
- Stem Cell Transplantation and Immunotherapy; Emory University School of Medicine; Atlanta United States
| |
Collapse
|
6
|
Waller E. Management of pancreatic neuroendocrine tumors. International Journal of Endocrine Oncology 2015. [DOI: 10.2217/ije.14.28] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Abstract: Despite the rarity of the disease, there has been significant recent progress in the management of pancreatic neuroendocrine tumors (PNETs). Arterial phase imaging and somatostatin scintigraphy are important parts of the diagnostic and staging work-up of PNETs. The slow growth rate of PNETs can make observation a reasonable initial option in low volume asymptomatic disease or allow debulking surgery in selected patients with advanced disease. Somatostatin analogs, angiogenesis and mTOR inhibitors have proven benefit for PNET patients in randomized trials while retrospective and single-arm trials using chemotherapy or peptide receptor radiation therapy also appear promising. This review summarizes key aspects in the management of PNETs with emphasis on the most recent advances in systemic therapy.
Collapse
|
7
|
Scheidt CE, Hasenburg A, Kunze M, Waller E, Pfeifer R, Zimmermann P, Hartmann A, Waller N. Are individual differences of attachment predicting bereavement outcome after perinatal loss? A prospective cohort study. J Psychosom Res 2012; 73:375-82. [PMID: 23062812 DOI: 10.1016/j.jpsychores.2012.08.017] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/04/2012] [Revised: 08/25/2012] [Accepted: 08/27/2012] [Indexed: 10/27/2022]
Abstract
OBJECTIVE The purpose of this study was to examine the influence of attachment, social support and the quality of the current partnership on the outcome of bereavement after perinatal loss. METHODS In a prospective cohort design 33 women after perinatal loss were approached on admission to hospital and reassessed four weeks, four months and nine months later. The initial assessment included the Adult Attachment Interview and self-report questionnaires for social support and quality of the current partnership. Bereavement outcome was assessed using measures of grief (MTS), depression and anxiety (HADS), psychological distress (BSI), somatisation (BSI-SOM) and symptoms of PTSD (PDS). RESULTS All measures of outcome showed a significant improvement over time. Standardized effect sizes between the initial assessment and nine month follow-up ranged between .36 for anxiety (HADS) and 1.02 for grief (MTS). Social support, quality of the partnership and secure attachment correlated inversely, and insecure preoccupied attachment correlated positively with the outcome measures. Preoccupied attachment was included as a predictor in two multivariate statistical models of non-linear regression analysis, one with somatisation (adjusted R2=.698, P=.016), the other with posttraumatic stress symptoms at nine month follow-up (adjusted R2=.416, P=.002) as target variable. Initial assessment scores of psychological distress predicted the course of the respective measure during follow-up (adjusted R2=.432, P=.014). CONCLUSION Attachment, social support and the quality of the current partnership have an impact on the course of bereavement after perinatal loss. Secondary prevention after the event may focus on these factors in order to offer specific counselling and support.
Collapse
Affiliation(s)
- C E Scheidt
- Freiburg Institute of Advanced Studies, Interdisciplinary Research Groups, Department of Psychosomatic Medicine and Psychotherapy, University Medical Center, Albert-Ludwigs-University Freiburg, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
8
|
Rodham K, Boxell E, McCabe C, Cockburn M, Waller E. Transitioning from a hospital rehabilitation programme to home: Exploring the experiences of people with complex regional pain syndrome. Psychol Health 2012; 27:1150-65. [DOI: 10.1080/08870446.2011.647820] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
9
|
Hossain S, Bhimani C, Chen Z, Ramalingam SS, Shin DM, Cohen C, Khuri FR, Waller E, Owonikoko TK. Comparison of native and adaptive immunity profiles of healthy volunteers and patients with well-differentiated thyroid cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.5585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
10
|
|
11
|
Waller E, Millage K, Blakely WF, Ross JA, Mercier JR, Sandgren DJ, Levine IH, Dickerson WE, Nemhauser JB, Nasstrom JS, Sugiyama G, Homann S, Buddemeier BR, Curling CA, Disraelly DS. Overview of hazard assessment and emergency planning software of use to RN first responders. Health Phys 2009; 97:145-156. [PMID: 19590274 DOI: 10.1097/01.hp.0000348464.78396.23] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
There are numerous software tools available for field deployment, reach-back, training and planning use in the event of a radiological or nuclear terrorist event. Specialized software tools used by CBRNe responders can increase information available and the speed and accuracy of the response, thereby ensuring that radiation doses to responders, receivers, and the general public are kept as low as reasonably achievable. Software designed to provide health care providers with assistance in selecting appropriate countermeasures or therapeutic interventions in a timely fashion can improve the potential for positive patient outcome. This paper reviews various software applications of relevance to radiological and nuclear events that are currently in use by first responders, emergency planners, medical receivers, and criminal investigators.
Collapse
Affiliation(s)
- E Waller
- University of Ontario Institute of Technology, Faculty of Energy Systems and Nuclear Science, 2000 Simcoe Street N., Oshawa, ON, Canada.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Lu Y, Li JM, Harris W, Waller E. Interactions Between DC And T-Cells Initiate Counter-Regulatory Immune Activities That Limits Amplification Of Allo-Immune Responses And GvHD. Biol Blood Marrow Transplant 2009. [DOI: 10.1016/j.bbmt.2008.12.381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
13
|
Hutcherson D, Surati M, Sanvidge K, Harvey D, Al-Baldawi R, Langston A, Flowers C, Lonial S, Kaufman J, Lechowicz M, Waller E. Pharmacokinetic (PK) Comparison Of Intravenous Versus Oral Busulfan Conditioning Regimens for Acute Myeloid Leukemia (AML) And Myelodysplastic Syndrome (MDS) Patients. Biol Blood Marrow Transplant 2009. [DOI: 10.1016/j.bbmt.2008.12.481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
14
|
Akhtari M, Lanston A, Waller E, Gal A. 389: Eosinophilic Pulmonary Syndrome as a Manifestation of Pulmonary Graft-versus-host-disease Following Hematopoietic Stem Cell Transplantation in Three Patients. Biol Blood Marrow Transplant 2008. [DOI: 10.1016/j.bbmt.2007.12.399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
15
|
|
16
|
Waller E, Ninan MJ, Roback J, Arellano M, Flowers C. The occurrence of idiopathic secondary post-transplant thrombocytopenia and the kinetics of platelet recovery predict survival in patients undergoing autologous hematopoietic progenitor cell transplantation. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.7109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
7109 Background: The frequency and clinical significance of secondary thrombocytopenia following initial engraftment in autologous hematopoietic progenitor cell transplantation (HPCT) is unknown. Methods: An IRB-approved retrospective study of thrombopoiesis in 359 patients transplanted with autologous blood (97%) or marrow (3%) who achieved transfusion-independent platelet engraftment to >50,000/mcL. Idiopathic secondary post-transplant thrombocytopenia (ISPT) was defined as >50% decline in blood platelets to <100,000/mcL in the absence of relapse or sepsis. Results: 62 of 359 study subjects (17%) met the criteria for ISPT within the first 100 days post-transplant. Patients with ISPT had more rapid platelet engraftment (17 + 5 days) versus non-ISPT patients (18 + 18 days; p=0.002) and partial recovery of platelet counts (median 96K/mcL) by day 75 post-transplant. The median survival for the entire population was 6.2 years with shorter survival in AML (1.3 years), breast cancer (6.2 years) and myeloma (5.5 years) than lymphoma patients (median not reached). Co- variates associated with post-transplant death (p<0.1) were entered into a multivariable logistic regression analysis stratified by cancer diagnosis at the time of transplant. Three factors were independently associated with worse survival: the number of prior chemotherapy regimens, failure to achieve a normal platelet counts post-transplant, and the occurrence of ISPT. A prognostic score was developed based upon the occurrence of ISPT and post-transplant platelet counts of <150,000/mcL. Survival of patients with both factors (n=25) was poor (15% alive at 5 years); patients with one factor (n=145) had 49% 5-year survival; patients with 0 factors (n=189) had 72% 5-year survival. Patients who failed to achieve a normal post-transplant platelet count received significantly fewer CD34+ cells/kg (P<0.001), while patients with ISPT received fewer CD34+CD38- cells/kg (P=0.001). Conclusion: ISPT reflects poor engraftment with long-term-repopulating CD34+ CD38- stem cells. The quantity and quality of autologous HPC in the graft are important prognostic variables for long-term survival. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- E. Waller
- Emory University, Atlanta, GA; Atlanta Medical Center, Atlanta, GA
| | - M. J. Ninan
- Emory University, Atlanta, GA; Atlanta Medical Center, Atlanta, GA
| | - J. Roback
- Emory University, Atlanta, GA; Atlanta Medical Center, Atlanta, GA
| | - M. Arellano
- Emory University, Atlanta, GA; Atlanta Medical Center, Atlanta, GA
| | - C. Flowers
- Emory University, Atlanta, GA; Atlanta Medical Center, Atlanta, GA
| |
Collapse
|
17
|
Arellano M, Flowers C, Waller E, Lonial S, Kaufman J, Winton E, Khoury H, Langston A. Reduced-intensity conditioning permits a significant graft vs leukemia (GvL) effect for acute leukemia. Biol Blood Marrow Transplant 2006. [DOI: 10.1016/j.bbmt.2005.11.218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
18
|
Arellano ML, Lonial S, Langston A, Flowers C, Heffner T, Hutcherson D, Winton E, Waller E. Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed dose vinorelbine, paclitaxel, etoposide, and cisplatin (VTEPA) for the treatment of relapsed/refractory lymphoma. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.6691] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
19
|
Waller E. Laboratory Notes. J Am Chem Soc 2004. [DOI: 10.1021/ja02154a621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
20
|
Somani J, Redei I, Cherry J, Tanner A, Lonial S, Bartlett V, Manion K, Waller E, Langston A. Infectious outcomes after alternative donor stem cell transplantation: a retrospective cohort comparison. Int J Infect Dis 2002. [DOI: 10.1016/s1201-9712(02)90268-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
21
|
Waller E. NOTE ON THE EXAMINATION OF BUTTER FAT AND ITS SUBSTITUTES. J Am Chem Soc 2002. [DOI: 10.1021/ja02129a012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
22
|
Waller E. NOTES ON SOME SANITARY EXAMINATIONS OF WATERS. J Am Chem Soc 2002. [DOI: 10.1021/ja02129a011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
23
|
Waller E. XV. AN EXAMINATION OF SOME OF THE METHODS FOR DETERMINING PHOSPHORUS IN IRON ORES. J Am Chem Soc 2002. [DOI: 10.1021/ja02154a016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
24
|
Waller E. REVIEW OF PAPERS ON ANALYTICAL CHEMISTRY (PROXIMATE) WHICH HAVE APPEARED DURING THE YEAR 1882. J Am Chem Soc 2002. [DOI: 10.1021/ja02154a029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
25
|
Chandler CF, Waller E. ANALYSES OF SOME MINERAL WATERS FROM TEXAS. J Am Chem Soc 2002. [DOI: 10.1021/ja02126a015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
26
|
|
27
|
Waller E. NOTES ON THE ANALYSIS OF ZINC ORES. J Am Chem Soc 2002. [DOI: 10.1021/ja02126a004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
28
|
Waller E. NOTE ON EXAMINATION OF SNOW WATER. J Am Chem Soc 2002. [DOI: 10.1021/ja02131a013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
29
|
|
30
|
Waller E. Laboratory Notes. J Am Chem Soc 2002. [DOI: 10.1021/ja02154a030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
31
|
Waller E. REVIEW OF PAPERS ON ANALYTICAL CHEMISTRY (INORGANIC) WHICH HAVE APPEARED DURING THE YEAR 1882. J Am Chem Soc 2002. [DOI: 10.1021/ja02154a025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
32
|
Waller E. NOTE ON THE ACTION OF WATERS UPON LEAD PIPE. J Am Chem Soc 2002. [DOI: 10.1021/ja02124a026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
33
|
Verdonschot EH, Angmar-Månsson B, ten Bosch JJ, Deery CH, Huysmans MC, Pitts NB, Waller E. Developments in caries diagnosis and their relationship to treatment decisions and quality of care. ORCA Saturday Afternoon Symposium 1997. Caries Res 2000; 33:32-40. [PMID: 9831778 DOI: 10.1159/000016493] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
This symposium report evaluates the achievements made in caries diagnostic research since the previous symposium held in 1992. The symposium aimed at presenting the state of the art of caries diagnostic methods, on presenting the links between caries diagnosis and subsequent treatment decisions and their effect on the treatment outcomes, particularly the quality of dental care. The variation among dentists in diagnosing (small) caries lesions and in treatment decision making is considerable. This has been explained by the imperfection of caries decision making tests, but also by making incorrect treatment decisions due to incorrect or partial understanding of diagnostic test parameters. Meta-analyses into the performance of caries diagnostic tests revealed that the available quantitative methods are very promising. It was concluded that these methods had high correlations with lesion depth. They were considered suitable to monitor small changes in lesions. Many obstacles have been experienced in attempting to transfer the outcomes of diagnostic research into clinical practice and it was concluded that caries diagnosis researchers should co-operate with manufacturers to introducing valid new diagnostic tools to the market. Main research priorities for the coming 10 years are to conduct cost-effectiveness and cost-utility studies of caries diagnostic tools, to continue to review the performances of diagnostic tests, to transfer diagnostic knowledge and experience to the general practitioners particularly by constructing evidence-based clinical guide-lines, to study the relationship between diagnosis and treatment decision, and to assess the effect of diagnostic and treatment decisions on the outcome of care.
Collapse
Affiliation(s)
- E H Verdonschot
- Department of Cariology and Endodontology, College of Dental Science, Medical Faculty, University of Nijmegen, The Netherlands.
| | | | | | | | | | | | | |
Collapse
|
34
|
Scheidt CE, Waller E, Malchow H, Ehlert U, Becker-Stoll F, Schulte-Mönting J, Lücking CH. Attachment representation and cortisol response to the adult attachment interview in idiopathic spasmodic torticollis. Psychother Psychosom 2000; 69:155-62. [PMID: 10773780 DOI: 10.1159/000012384] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
OBJECTIVE The study investigates individual differences in the mental representation of attachment and their impact on the cortisol response to psychosocial stress in idiopathic spasmodic torticollis (IST). It was hypothesized (a) that in IST insecure attachment is more prevalent than in a non-clinical control group and (b) that subjects with dismissing attachment respond with higher physiological arousal to a specific stimulus activating the attachment behavioural system than subjects with secure attachment. METHOD 20 patients with IST and 20 healthy controls matched for age and sex underwent the Adult Attachment Interview, an hour-long, semiclinical interview on attachment experiences. During the interview salivary cortisol levels were monitored. The subjects' mental state with regard to attachment was classified using the attachment Q-sort method. Anxiety and depression were measured as potential covariates of the adrenocortical stress response. RESULTS Compared to the non-clinical group, dismissing attachment was strongly overrepresented in IST. In IST, but not in the healthy control group, dismissing attachment correlated with an elevated cortisol response to the interview. CONCLUSION In clinical, but not in non-clinical samples dismissing attachment may be associated with increased vulnerability to psychosocial stress. The factors contributing to this interaction are not yet fully elucidated.
Collapse
Affiliation(s)
- C E Scheidt
- Abteilung für Psychosomatik und Psychotherapeutische Medizin, Universitätsklinik Freiburg, Deutschland.
| | | | | | | | | | | | | |
Collapse
|
35
|
Abstract
We investigated alexithymia and the mental representation of attachment in idiopathic spasmodic torticollis (IST). It was hypothesized a) that alexithymia in IST is more prevalent than in a nonclinical control group and b) that significant correlations emerge between alexithymia and a dismissing attachment representation. Twenty patients with IST and 20 healthy controls matched for age and sex were administered the Toronto Alexithymia Scale (TAS-20) and the Adult Attachment Interview (AAI). Attachment was classified using the Attachment Interview Q-sort. IST patients scored significantly higher on the measure of alexithymia than subjects in the comparison group. In IST a dismissing attachment representation was significantly more frequent than in the control group. Across the total sample, externally oriented thinking correlated positively with dismissing attachment, and both externally oriented thinking and difficulty communicating feelings (two of the three subscales of the TAS-20) correlated inversely with secure attachment. Alexithymia is more prevalent in IST than in normals. As was hypothesized, alexithymia in adults is significantly interrelated with the mental representation of attachment.
Collapse
Affiliation(s)
- C E Scheidt
- Abteilung für Psychosomatik und Psychotherapeutische Medizin, Universitätsklinik Freiburg, Germany
| | | | | | | | | | | | | |
Collapse
|
36
|
Bingham SA, Murphy J, Waller E, Runswick SA, Neale G, Evans D, Cummings JH. para-amino benzoic acid in the assessment of completeness of 24-hour urine collections from hospital outpatients and the effect of impaired renal function. Eur J Clin Nutr 1992; 46:131-5. [PMID: 1559515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Eighteen (29%) of 24-h urine collections made by 63 hospital outpatients attending a gastroenterology clinic were incomplete, as judged by 24 h urine recovery of an oral marker, para-amino benzoic acid (PABA), despite more than the usual efforts to obtain complete collections. Incomplete collections contained significantly less sodium, urea and total nitrogen than full collections. Average outputs were 134 mmol and 103 mmol per day for sodium (P less than 0.02); 301 mmol and 223 mmol for urea (P less than 0.001); and 10.1 g and 8.3 g nitrogen (P less than 0.01) in the complete and incomplete collections respectively. In renal outpatients with a plasma creatinine in excess of 125 mumol per litre, urine recoveries of PABA were reduced, but within the expected range in renal patients whose plasma creatinine was normal.
Collapse
Affiliation(s)
- S A Bingham
- MRC Dunn Clinical Nutrition Centre, Cambridge, U.K
| | | | | | | | | | | | | |
Collapse
|
37
|
Waller E. The new environmentalist. Environ Monit Assess 1991; 19:261-273. [PMID: 24233944 DOI: 10.1007/bf00401316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
This paper looks at the increasingly complex problems which face physical planners in the urban environment and considers the type of training required in the future for those who have to advise the government of the day on physical planning matters.Using the examples of planning problems which have been experienced in Hong Kong and Saudi Arabia, an analysis shows that they fall into three main categories: (a) physical problems (b) social problems, and (c) visual problems.It is considered that the conventional professionals do not possess the necessary basic training skills to deal with these problems as a whole, nor to discover the hidden opportunities. This is particularily relevant in the context of the growing 'green' debates which are becoming of increasing importance worldwide.As populations grow, the demand from pressure groups for scarce land resources will become more and more intensive. Singapore may face these problems because the government whishes to increase the population from 2(1/2) to four million.In conclusion it is considered that we shall need a new type of environmental planner in the future. This environmentalist should have a basic training in the earth sciences, the social sciences and the visual arts.
Collapse
Affiliation(s)
- E Waller
- School of Architecture, Faculty of Architecture and Building, National University of Singapore, Kent Ridge, Republic of Singapore, 0511
| |
Collapse
|
38
|
Waller E. EXPERIMENTS ON MILK ANALYSIS. J Am Chem Soc 1891. [DOI: 10.1021/ja02124a006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
39
|
|
40
|
|
41
|
Waller E. Proceedings of the American Society of Public Analysts. Analyst 1885. [DOI: 10.1039/an8851000223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
42
|
Waller E. Proceedings of the American Society of Public Analysts. Analyst 1885. [DOI: 10.1039/an8851000123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
43
|
Waller E. Proceedings of the American Society of Public Analysts. Analyst 1885. [DOI: 10.1039/an8851000105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
44
|
Waller E, Martin EW. An examination of mustards manufactured and sold in New York City. Analyst 1884. [DOI: 10.1039/an8840900166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
45
|
Waller E. V. THE WATER SUPPLY OF THE CITY OF NEW YORK. J Am Chem Soc 1882. [DOI: 10.1021/ja02154a005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
46
|
Waller E. ADDITIONS TO THE LIBRARY OF THE AMERICAN CHEMICAL SOCIETY. J Am Chem Soc 1880. [DOI: 10.1021/ja02132a001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
47
|
Waller E. Report on Disinfection and Disinfectants. Public Health Pap Rep 1873; 1:459-471. [PMID: 19599880 PMCID: PMC2272664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
|